<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>2152231</identifier>
<setSpec>0034-9887</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Chesta, J</dc:author>
<dc:author>Hurtado, C</dc:author>
<dc:author>Velasco, M</dc:author>
<dc:author>Brahm, J</dc:author>
<dc:author>Antezana, C</dc:author>
<dc:author>Gidi, J</dc:author>
<dc:author>Novoa, X</dc:author>
<dc:author>Latorre, R</dc:author>
<dc:description xml:lang="en">We randomized 31 cirrhotic patients with tense ascites to a Group A receiving only diuretic therapy (spironolactone, furosemide, n = 14) or a Group B treated with paracentesis and intravenous albumin infusion (n = 17). Ascites was eliminated in 88% of patients in Group B compared to 57% of patients in Group A (p &lt; 0.05). Complications developed in 4 patients in Group A and 2 patients in Group B. Paracentesis was associated to a mild and transient reduction in mean arterial pressure and a significant rise in urinary output. Duration of hospital stay was 5 +/- 3 days in Group B and 22 +/- 6 in Group A (p &lt; 0.001). Survival and likelihood of readmission for ascites was similar in both groups. Our results suggest that paracentesis plus intravenous albumin infusion is a fast, safe and effective therapy for tense ascites in cirrhotic patients.</dc:description>
<dc:type>Clinical Trial</dc:type>
<dc:language>es</dc:language>
<dc:date>1990 Aug </dc:date>
<dc:title xml:lang="es">Paracentesis con infusión de albumina en el tratamiento de la ascitis a tensión en pacientes cirróticos.</dc:title>
<dc:title xml:lang="en">[Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients].</dc:title>
<dc:publisher>Revista medica de Chile</dc:publisher>
</metadata>
</record>
</pubmed-document>
